The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical View

Autor: Tambaro FP, De Novellis D, Wierda WG

Publikováno v: Journal of Experimental Pharmacology, Vol Volume 13, Pp 923-935 (2021)

Francesco Paolo Tambaro,1 Danilo De Novellis,1,2 William G Wierda3 1Unità Operativa di Trapianto di Midollo Osseo e Servizio Trasfusionale, Azienda Ospedaliera di Rilievo Nazionale Santobono-Pausilipon, Napoli, Italy; 2Department of Precision Medici

Externí odkaz: https://doaj.org/article/986d7161af1b4df1b23594f692f378f6

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Autor: Rawstron, AC, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, K-A, Liptrot, S, O'Brien, D, de Tute, RM, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, AP, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, JL, Stetler-Stevenson, M, Yuan, C, Broome, HE, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, CM, Emerson, R, Robins, HS, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, TJ, Wierda, WG, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P, CLL, ERIC European Res Initiative

Publikováno v: Leukemia
Leukemia, vol 30, iss 4
Leukemia, 30(4), 929-936. Nature Publishing Group
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

In chronic lymphocytic leukemia (CLL) the level of minimal residual disease (MRD) after therapy is an independent predictor of outcome. Given the increasing number of new agents being explored for CLL therapy, using MRD as a surrogate could greatly r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223b87a88cadbba63e43e546bd4fa680

Front‐line Treatment with Ofatumumab in Elderly Unfit Patients with CLL

Autor: Vitale, C, Ciccone, M, Hinojosa, C, Keating, Mj, Pemmaraju, N, O'Brien, S, Wierda, Wg, Thomas, D, Borthakur, G, Ohanian, M, Burger, Ja, Ferrajoli, A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::159a1d3523287d400880df0747ddc73e
http://hdl.handle.net/2318/1695863

Other cancers in longterm survivor patients with chronic lymphocytic leukemia

Autor: Falchi, L, Vitale, C, Keating, Mj, Lerner, S, Wang, X, Elhor Gbito KY, Strom, Ss, Wierda, Wg, Ferrajoli, A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::b5d1edb89873f9e122a656ba546fd1ff
http://hdl.handle.net/2318/1695864

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.